van der Leij Femke, Schultz Willibrord C M Weijmar, van de Wiel Harry, van Leeuwen Jules H Schagen
St. Antonius Ziekenhuis, Nieuwegein, Afd. Gynaecologie, the Netherlands.
Ned Tijdschr Geneeskd. 2010;154:A1341.
Premenstrual syndrome (PMS) is characterised by the occurrence of physical and psychological symptoms during the luteal phase of almost every menstrual cycle. These symptoms disappear at the beginning of menstruation, and a symptom-free period of at least a week ensues. Premenstrual dysphoric disorder (PMDD) is a variation of PMS, with predominantly psychological symptoms. The aetiology of PMD and PMDD is not known. A possible explanation however is an abnormal, stronger reaction to physiologically normal hormonal fluctuations. Diagnosing PMS and PMDD requires prospective daily monitoring of symptoms over at least two menstrual cycles. No effective medication for the treatment of PMS has been registered in the Netherlands. In randomized placebo-controlled trials selective serotonin reuptake inhibitors and oral contraceptives containing drosperinone have been found to have a positive effect on the physical and psychological symptoms of PMS and PMDD.
经前综合征(PMS)的特征是几乎在每个月经周期的黄体期都会出现身体和心理症状。这些症状在月经开始时消失,随后会有至少一周的无症状期。经前烦躁障碍(PMDD)是PMS的一种变体,主要表现为心理症状。PMD和PMDD的病因尚不清楚。然而,一种可能的解释是对生理上正常的激素波动有异常强烈的反应。诊断PMS和PMDD需要在至少两个月经周期内对症状进行前瞻性的每日监测。荷兰尚未注册用于治疗PMS的有效药物。在随机安慰剂对照试验中,已发现选择性5-羟色胺再摄取抑制剂和含屈螺酮的口服避孕药对PMS和PMDD的身体和心理症状有积极作用。